Up-to-date scientific reports on the geographical bovine spongiform encephalopathy (BSE) risk

The European Food Safety Authority (EFSA) has issued today seven up-to-date scientific reports on the Geographical Bovine Spongiform Encephalopathy (BSE) Risk (GBR) assessments for Australia, Canada, Mexico, Norway, South Africa Sweden and the United States of America.

While Australia’s GBR level I (i.e. presence of BSE in domestic cattle is highly unlikely) is maintained, that of Norway has been raised to level II (presence of BSE unlikely but not excluded), Sweden remains at GBR level II and those of Canada and the United States have been raised to level III (presence of BSE likely but not confirmed, or confirmed at a lower level) following a new assessment taking into account the most recent evidence. EFSA’s Scientific Expert Working Group on geographic BSE risk assessment also evaluated the status of Mexico and South Africa which were classified as level III.

In 2003 EFSA was requested by the European Commission (EC) to re-assess the Geographical Bovine Spongiform Encephalopathy (BSE) risk (GBR) for 13 countries: Australia, Botswana, Canada, Costa Rica, El Salvador, Nicaragua, Namibia, Norway, Mexico, Panama, Swaziland, Sweden and the United States. Although the European Commission did not specifically seek advice from EFSA relating to the appearance of BSE in South Africa, the working group decided to carry out a risk assessment for this country under a self-tasking mandate in order to allow for a meaningful evaluation of the three other countries in the Southern African Region for which a GBR assessment was requested (i.e. Botswana, Namibia, Swaziland). EFSA’s Scientific Expert Working Group on the Assessment of the GBR has completed to date those assessments relating to Australia, Canada, Mexico, Norway, South Africa, Sweden and the United States of America. The GBR assessments for the remaining countries will be finalized by the end of 2004.

In conducting the GBR assessments, EFSA’s GBR working group followed the methodology developed by the former Scientific Steering Committee of DG Health and Consumer Safety (DG SANCO) of the European Commission which is described in its final opinion on GBR assessment . The risk assessments published today are based on up-to-date data provided by the countries concerned as well as other sources of data (i.e. Eurostat and country export data) covering the period of 1980 to 2003.

A detailed analysis for each country is presented in the Scientific Reports


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
You might also like...
Emulsifiers and heart health: a prospective cohort study reveals associations